Neurology
Genetic studies can help to correctly diagnose patients with hereditary neurological diseases such as movement disorders, neuromuscular disorders, intellectual disability or epilepsy, among others.
Home » Neurology
Clinical areas
Broader studies
Documentation
- EDTA blood (1x 5 ml)
- Saliva (specific Isohelix kit)
- Buccal exudate (2x sterile isopes)
- gDNA (>30 ng/μl in >100 μl TE buffer)
Remember to label each sample with the patient's first and last name or with the identifier used on the request form.
Movement disorders
The term 'movement disorders' refers to a group of nervous system conditions that cause an increase in abnormal movements, which may be voluntary or involuntary. Movement disorders can also cause slow or reduced movements. We offer the study of the main movement disorders such as dystonia and Parkinson's disease.
Studies included
Parkinson's disease
DG Parkinson (16 genes)
Adult-onset Parkinson's disease (8 genes)
Early-onset Parkinson's disease (11 genes)
Parkinsonian disorders
DG Parkinsonian Disorders (17 genes)
ATP6AP2, COQ2, DCTN1, GCH1, LRRK2, LYST, MAPT, NUS1, OPA1, PLA2G6, PTRHD1, RAB39B, SPG11, TWNK, ZFYVE26, SYNJ1, VPS13C.
Dystonia
DG Dystonia (88 genes)
Isolated Dystonia (6 genes)
Dystonia with Parkinsonism (5 genes)
Myoclonic Dystonia (1 gene)
Paroxysmal Dystonia with other dyskinesia (4 genes)
Complex Dystonia (73 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Dementia
Dementia is an umbrella term that describes a wide range of symptoms associated with memory impairement and other thinking skills, leading to a reduction in a person's ability to carry out daily activities. Alzheimer's disease accounts for 60-80% of cases. The study of genes associated with different types of dementia is included.
Studies included
DG Dementia (18 genes)
Alzheimer's disease (8 genes)
Semantic Dementia (4 genes)
Frontotemporal Dementia (15 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Neuromuscular diseases
Neuromuscular diseases are a group of more than 150 progressive and chronic neurological conditions, mostly of genetic origin, which cause loss of muscle strength and associated muscle and nerve degeneration. Through the different panels we address the study of various neuromuscular diseases such as neuropathies, myopathies and muscular dystrophies, diseases with motor neuron involvement and myasthenic syndromes as well as other syndromes with hypotonia, myotonia and/or weakness.
Studies included
Motor neurone disease
DG Motoneuron (88 genes)
ALS (45 genes)
Spinal Muscular Atrophy (2 genes)
Frontotemporal dementia with motor neuron involvement (7 genes)
Neuropathies
DG Neuropathy (209 genes)
Charcot-Marie-Tooth disease (106 genes)
Motor neuropathy (38 genes)
Sensory neuropathy (15 genes)
Congenital Myasthenia
DG Congenital Myasthenia (36 genes)
Myopathies
DG Myopathies (210 genes)
Muscular Dystrophy (71 genes)
Facioscapulohumeral dystrophy (6 genes)
Dystrophinopathy (Duchenne and Becker) (2 genes)
Limb-girdle Muscular Dystrophy (29 genes)
Oculopharyngeal Muscular Dystrophy (1 gene)
Emery-Dreifuss dystrophy (7 genes)
Myotonic Dystrophy (2 genes)
Distal Myopathy (16 genes)
Congenital Myopathy (36 genes)
Nemaline Myopathy (9 genes)
Central core myopathy (1 gene)
Metabolic Myopathy (107 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Leukodystrophies
Leukodystrophies represent a heterogeneous group of hereditary degenerative myelin diseases of the brain that result in extensive white matter involvement. The clinical there is a wide-range of different clinical manifestations which makes diagnosis difficult. This study involves the analysis of 72 genes related to different types of leukodystrophy.
Studies included
DG Leukodystrophies (79 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Spastic paraparesis
Hereditary spastic paraparesis (HSP) comprises a genetically and clinically heterogeneous group of neurodegenerative disorders whose predominant signs and symptoms are weakness and spasticity of the lower extremities. We offer different approaches to the study of various types of spastic paraparesis, as well as a general panel that includes 84 genes associated with the pathology.
Studies included
DG Spastic Paraparesis (84 genes)
Spastic Paraparesis AD Complex (11 genes)
Spastic Paraparesis AD Pure (16 genes)
Spastic Paraparesis AR Complex (48 genes)
Spastic Paraparesis AR Pure (8 genes)
X-Linked Spastic Paraparesis (3 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Epilepsy
Epilepsy is a disorder of the central nervous system in which normal brain activity is disturbed, causing seizures or periods of unusual behaviour and sensations, and even loss of consciousness. The underlying causes are multiple and heterogeneous. Through different studies we analyse various epilepsy phenotypes. We also include a specific panel for the study of epileptic syndromes of neonatal and infantile onset, as well as a general panel for more complex cases.
Studies included
DG Epilepsy (195 genes)
Neonatal and Childhood Epilepsy (108 genes)
Epileptic Encephalopathy (88 genes)
Generalised Epilepsy (10 genes)
Generalised epilepsy with febrile seizures plus (9 genes)
Focal epilepsy (30 genes)
Myoclonic Epilepsy (54 genes)
Infantile and Juvenile Myoclonic Epilepsy (10 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Autism spectrum disorder
Autism Spectrum Disorders (ASD) are defined as a chronic neurological dysfunction that can manifest through a series of symptoms related to social interaction, communication and lack of flexibility in reasoning and behaviour. The complexity of the clinical manifestations suggests a multi-causal aetiology with genetic alterations being the main cause. Using a targeted exome, we analyse more than 420 genes with a proven association with ASD.
Studies included
DG Autistic Spectrum Disorder (423 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Intellectual disability
Intellectual disability refers to a group of cognitive disorders of heterogeneous and complex cause with a genetic component in most cases. Advances in genetics have increased the diagnostic rate of current studies by up to 30-40% of patients. Our targeted exome analyses more than 580 genes associated with intellectual disability.
Studies included
DG Intellectual Disability (587 genes)
X-linked Intellectual Disability (127 genes)
Fragile X syndrome (1 gene)
Angelman Syndrome
Prader-Willi syndrome
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Ataxia
Ataxia is a motor disorder characterized by a decreased ability to coordinate movements, manifesting as tremor of body parts during voluntary movements, difficulty in making precise movements or difficulty in maintaining balance.
Studies included
DG Ataxias (150 genes)
DG Cerebellar Autosomal Dominant Ataxias (30 genes)
Spinocerebellar Ataxia (9 genes)
Expanded Spinocerebellar Ataxia (26 genes)
Spinocerebellar Ataxia Types SCA1, SCA2, SCA3, SCA6, SCA7 (5 genes)
Spinocerebellar Ataxia without Axonal Neuropathy (6 genes)
DG Episodic Ataxia (6 genes)
DG Spastic Ataxia (9 genes)
DG Autosomal Recessive Ataxia (18 genes)
Cerebellar Ataxia with Sensory Neuropathy (3 genes)
Friedreich's Ataxia (1 gene)
Spinocerebellar Ataxia with Axonal Neuropathy (7 genes)
Ataxia-telangiectasia (1 gene)
DG X-linked ataxias (5 genes)
Fragile X-associated tremor/ataxia syndrome (5 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days